Catalyst Wire Dossier Catalyst Wire Dossier

ALD518

· CSL Behring
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ALD518, covering 2020-07-09 to 2021-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects [Phase 2]

See pricing